| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9354021 | Journal of Orthopaedic Research | 2005 | 8 Pages |
Abstract
In summary, early periprosthetic bone loss is associated with a transient expansion of the bone remodeling space. Bisphosphonate therapy reduces femoral calcar bone loss and bone turnover after THA, but did not influence cup migration in this study. Acute changes in biochemical markers predict femoral periprosthetic bone loss.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
J.Mark Wilkinson, Alison C. Eagleton, Ian Stockley, Nicola F.A. Peel, Andrew J. Hamer, Richard Eastell,